184 related articles for article (PubMed ID: 11567659)
1. High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists.
Wang PR; Guo Q; Ippolito M; Wu M; Milot D; Ventre J; Doebber T; Wright SD; Chao YS
Eur J Pharmacol; 2001 Sep; 427(3):285-93. PubMed ID: 11567659
[TBL] [Abstract][Full Text] [Related]
2. Antidyslipidemic action of fenofibrate in dyslipidemic-diabetic hamster model.
Rizvi F; Puri A; Bhatia G; Khanna AK; Wulff EM; Rastogi AK; Chander R
Biochem Biophys Res Commun; 2003 May; 305(2):215-22. PubMed ID: 12745061
[TBL] [Abstract][Full Text] [Related]
3. A novel peroxisome proliferator-activated receptor alpha/gamma dual agonist demonstrates favorable effects on lipid homeostasis.
Guo Q; Sahoo SP; Wang PR; Milot DP; Ippolito MC; Wu MS; Baffic J; Biswas C; Hernandez M; Lam MH; Sharma N; Han W; Kelly LJ; MacNaul KL; Zhou G; Desai R; Heck JV; Doebber TW; Berger JP; Moller DE; Sparrow CP; Chao YS; Wright SD
Endocrinology; 2004 Apr; 145(4):1640-8. PubMed ID: 14701675
[TBL] [Abstract][Full Text] [Related]
4. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
[TBL] [Abstract][Full Text] [Related]
5. Anti-hyperlipidemic and insulin sensitizing activities of fenofibrate reduces aortic lipid deposition in hyperlipidemic Golden Syrian hamster.
Srivastava RA; He S
Mol Cell Biochem; 2010 Dec; 345(1-2):197-206. PubMed ID: 20740305
[TBL] [Abstract][Full Text] [Related]
6. Cooked rice prevents hyperlipidemia in hamsters fed a high-fat/cholesterol diet by the regulation of the expression of hepatic genes involved in lipid metabolism.
Choi WH; Gwon SY; Ahn J; Jung CH; Ha TY
Nutr Res; 2013 Jul; 33(7):572-9. PubMed ID: 23827132
[TBL] [Abstract][Full Text] [Related]
7. [A dyslipidemia animal model induced by poloxamer 407 in golden hamsters and pilot study on the mechanism].
Liu Q; Liu SN; Li LY; Chen ZY; Lei L; Zhang N; Shen ZF
Yao Xue Xue Bao; 2011 Apr; 46(4):406-11. PubMed ID: 21751494
[TBL] [Abstract][Full Text] [Related]
8. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
[TBL] [Abstract][Full Text] [Related]
9. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet.
Dixon JL; Stoops JD; Parker JL; Laughlin MH; Weisman GA; Sturek M
Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2981-92. PubMed ID: 10591679
[TBL] [Abstract][Full Text] [Related]
10. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085
[TBL] [Abstract][Full Text] [Related]
11. The effect of fenofibrate on insulin sensitivity and plasma lipid profile in non-diabetic males with low high density lipoprotein/dyslipidaemic syndrome.
Yong QW; Thavintharan S; Cheng A; Chew LS
Ann Acad Med Singap; 1999 Nov; 28(6):778-82. PubMed ID: 10672386
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of fish liver preparations of sea bass (Lates calcarifer) versus gemfibrozil in high fat diet-induced lipid-intolerant rats.
Rizvi F; Iftikhar M; George JP
J Med Food; 2003; 6(2):123-8. PubMed ID: 12935323
[TBL] [Abstract][Full Text] [Related]
13. Fenofibrate ameliorates diabetic and dyslipidemic profiles in KKAy mice partly via down-regulation of 11beta-HSD1, PEPCK and DGAT2. Comparison of PPARalpha, PPARgamma, and liver x receptor agonists.
Srivastava RA
Eur J Pharmacol; 2009 Apr; 607(1-3):258-63. PubMed ID: 19245804
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity.
Guerre-Millo M; Gervois P; Raspé E; Madsen L; Poulain P; Derudas B; Herbert JM; Winegar DA; Willson TM; Fruchart JC; Berge RK; Staels B
J Biol Chem; 2000 Jun; 275(22):16638-42. PubMed ID: 10828060
[TBL] [Abstract][Full Text] [Related]
15. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
Choi WS; Lee JJ; Kim Y; Kim IS; Zhang WY; Myung CS
Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha.
Nagai Y; Nishio Y; Nakamura T; Maegawa H; Kikkawa R; Kashiwagi A
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1180-90. PubMed ID: 11934685
[TBL] [Abstract][Full Text] [Related]
17. Induction of endogenous genes by peroxisome proliferator activated receptor alpha ligands in a human kidney cell line and in vivo.
Liu PC; Huber R; Stow MD; Schlingmann KL; Collier P; Liao B; Link J; Burn TC; Hollis G; Young PR; Mukherjee R
J Steroid Biochem Mol Biol; 2003 May; 85(1):71-9. PubMed ID: 12798359
[TBL] [Abstract][Full Text] [Related]
18. Modulating effects of chlorogenic acid on lipids and glucose metabolism and expression of hepatic peroxisome proliferator-activated receptor-alpha in golden hamsters fed on high fat diet.
Li SY; Chang CQ; Ma FY; Yu CL
Biomed Environ Sci; 2009 Apr; 22(2):122-9. PubMed ID: 19618689
[TBL] [Abstract][Full Text] [Related]
19. Regulation of lipid metabolism and gene expression by fenofibrate in hamsters.
Guo Q; Wang PR; Milot DP; Ippolito MC; Hernandez M; Burton CA; Wright SD; Chao Y
Biochim Biophys Acta; 2001 Oct; 1533(3):220-32. PubMed ID: 11731332
[TBL] [Abstract][Full Text] [Related]
20. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
